All Stories

  1. Correction to Development of an Effective Functional Lipid Anchor for Membranes (FLAME) for the Bioorthogonal Modification of the Lipid Bilayer of Mesenchymal Stromal Cells
  2. Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival
  3. Three-Dimensional Breast Cancer Model to Investigate CCL5/CCR1 Expression Mediated by Direct Contact between Breast Cancer Cells and Adipose-Derived Stromal Cells or Adipocytes
  4. Development of an Effective Functional Lipid Anchor for Membranes (FLAME) for the Bioorthogonal Modification of the Lipid Bilayer of Mesenchymal Stromal Cells
  5. Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma
  6. SiaNAl can be efficiently incorporated in glycoproteins of human mesenchymal stromal cells by metabolic glycoengineering
  7. Software JimenaE allows efficient dynamic simulations of Boolean networks, centrality and system state analysis
  8. Vitamin D Receptor Expression Is Significantly Decreased in Bone Metastases Compared to Matched Primary Breast Cancer Tumours
  9. Bone Metastases of Diverse Primary Origin Frequently Express the VDR (Vitamin D Receptor) and CYP24A1
  10. The vitamin D receptor is widely expressed in bone metastases from various types of primary tumors
  11. Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans
  12. Mesenchymal Stromal Cells (MSCs) Isolated from Various Tissues of the Human Arthritic Knee Joint Possess Similar Multipotent Differentiation Potential
  13. Epigenetics and Noncoding RNA – Principles and Clinical Impact
  14. Epigenetics of Osteoporosis
  15. Impaired regenerative capacity and senescence‐associated secretory phenotype in mesenchymal stromal cells from samples of patients with aseptic joint arthroplasty loosening
  16. Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
  17. The influence of differently functionalized nanodiamonds on proliferation, apoptosis and EMT/MET phenomena in 2D and 3D tumor cell cultures
  18. Phosphodiesterase 10A Is a Mediator of Osteogenic Differentiation and Mechanotransduction in Bone Marrow-Derived Mesenchymal Stromal Cells
  19. Interaktion zwischen Muskel und Knochen – ein Wechselspiel zwischen Physik und Biologie
  20. Interactions between Muscle and Bone—Where Physics Meets Biology
  21. Tendon-derived stem cells from the long head of the biceps tendon
  22. NOTCH Signaling Is Activated through Mechanical Strain in Human Bone Marrow-Derived Mesenchymal Stromal Cells
  23. Teriparatid – Das molekulare und klinische Profil bei der Therapie der Osteoporose
  24. The inflamed biceps tendon as a pain generator in the shoulder: A histological and biomolecular analysis
  25. Response to Letter to the Editor: Epigenetic Aging in Osteoporosis
  26. Mesenchymal Stem Cells Isolated from the Anterior Cruciate Ligament: Characterization and Comparison of Cells from Young and Old Donors
  27. Physical contact between mesenchymal stem cells and endothelial precursors induces distinct signatures with relevance to the very early phase of regeneration
  28. Activation of ERK5 by bisphosphonates
  29. Epidermal growth factor as a mechanosensitizer in human bone marrow stromal cells
  30. JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
  31. Human Platelet Lysate versus Fetal Calf Serum: These Supplements Do Not Select for Different Mesenchymal Stromal Cells
  32. Dissection of mechanoresponse elements in promoter sites of the mechanoresponsive CYR61 gene
  33. Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells –Implications for myeloma bone disease
  34. Matrix Metalloproteinase Responsive Delivery of Myostatin Inhibitors
  35. The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone Disease
  36. Acute phase serum amyloid A induces proinflammatory cytokines and mineralization via toll-like receptor 4 in mesenchymal stem cells
  37. Characterization of bursa subacromialis-derived mesenchymal stem cells
  38. Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells
  39. Osteoblast-Specific Krm2 Overexpression and Lrp5 Deficiency Have Different Effects on Fracture Healing in Mice
  40. Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells
  41. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer
  42. Antiresorptiva in der Behandlung von Knochenmetastasen
  43. Effects of phytoestrogens and other plant-derived compounds on mesenchymal stem cells, bone maintenance and regeneration
  44. Uncovering the cellular and molecular changes in tendon stem/progenitor cells attributed to tendon aging and degeneration
  45. Bone tissue engineering in osteoporosis
  46. The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors
  47. 1,25-Dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity
  48. Differential response of the promoter elements AP1 and SP1 to mechanical strain
  49. Differentiation studies in human mesenchymal stem cells and SAOS-2 cells after stimulation with extracts of Cimicifuga racemosa
  50. The transcriptome of hMSC from osteoporotic donors is distinct from hMSC of 80+ donors
  51. Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells
  52. 1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity
  53. Pathophysiologie des Knochenstoffwechsels bei Osteonekrosen im Zusammenhang mit starker antiresorptiver Therapie
  54. In situ guided tissue regeneration in musculoskeletal diseases and aging
  55. PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages
  56. Effects of Black Cohosh ( Cimicifuga racemosa ) extract on apoptosis and proliferation rates in HMSCS, MCF7, MDA-MB-231 and LNCAP cells
  57. Activin-Antagonisten in der Therapie der Osteoporose
  58. Zelluläre Defekte und Regulationsstörungen bei der Heilung osteoporotischer Frakturen
  59. Molekularbiologische Aspekte und Signalwege von Vitamin D
  60. Pathogenese des Morbus Paget
  61. A small scale cell culture system to analyze mechanobiology using reporter gene constructs and polyurethane dishes
  62. Functional Signature of Human Islet-Derived Precursor Cells Compared to Bone Marrow-Derived Mesenchymal Stem Cells
  63. Trace Elements and Bone
  64. Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells
  65. Estrogen receptor and Wnt signaling interact to regulate early gene expression in response to mechanical strain in osteoblastic cells
  66. Autocrine Fibroblast Growth Factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells
  67. Sexualsteroide in der Homöostase des Knochens
  68. Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells
  69. FGF23 is a putative marker for bone healing and regeneration
  70. 1,25 vitamin D3 induces ageing of mesenchymal stem cells
  71. Microarray analyses reveal relevant differences in the transcriptome of human BM-MSC of patients with osteoporosis
  72. Rachitis in Nigeria – Spielen neben extremem Kalziummangel auch geologische und genetische Faktoren eine Rolle?
  73. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation
  74. Die Gorham-Stout-Erkrankung
  75. Pathophysiologie des Knochenstoffwechsels
  76. Biology of Mesenchymal Stem Cells
  77. Short-time zoledronic acid pretreatment stimulates osteogenic differentiation of human mesenchymal stem cells
  78. Spurenelemente und Knochengesundheit
  79. Effects of high glucose on mesenchymal stem cell proliferation and differentiation
  80. Selenium deficiency as a putative risk factor for osteoporosis
  81. Influence of hormones on osteogenic differentiation processes of mesenchymal stem cells
  82. Frakturheilung bei Osteoporose
  83. Selenium Supplementation Restores the Antioxidative Capacity and Prevents Cell Damage in Bone Marrow Stromal Cells In Vitro
  84. Fgf23
  85. Vitamin D signaling is modulated on multiple levels in health and disease
  86. Erbliche und erworbene Erkrankungen des Phosphatstoffwechsels
  87. Down-Regulation by Nuclear Factor κB of Human 25-Hydroxyvitamin D3 1α-Hydroxylase Promoter
  88. Regulation of human 25-hydroxyvitamin D3 1α-hydroxylase promoter activity by NFκB via multiple NFκB response elements
  89. Genetik der Osteoporose
  90. Expression and Regulation of Thioredoxin Reductases and Other Selenoproteins in Bone
  91. Expression of selenoproteins in monocytes and macrophages — Implications for the immune system
  92. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells - regulation by 1,25-dihydroxyvitamin D3and selenite
  93. The thioredoxin reductase/thioredoxin system in cells of the monocyte/macrophage pathway of differentiation
  94. Reverse Transcriptase-Polymerase Chain Reaction Analysis of Thyrocyte-Relevant Genes in Fine-Needle Aspiration Biopsies of the Human Thyroid
  95. Grundlagen und Klinik der Knochenmetastasen
  96. The Human Proteosome